Heterozygosity for the BLM(Ash) mutation and cancer risk.
Cleary SP, Zhang W, Di Nicola N, Aronson M, Aube J, Steinman A, Haddad R, Redston M, Gallinger S, Narod SA, Gryfe R.
Cleary SP, et al. Among authors: gallinger s.
Cancer Res. 2003 Apr 15;63(8):1769-71.
Cancer Res. 2003.
PMID: 12702560